NCI Drug Discovery Program Pays Off

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 4
Volume 4
Issue 4

ROCKVILLE, Md--Bruce Chabner, MD, director of the NCI Division of Cancer Treatment, said that over the past decade, NCI's drug discovery and development programs have produced seven new drugs currently being used to treat cancer and AIDS. The program cost about $1.4 billion: $200 million for every New Drug Application filed.

ROCKVILLE, Md--Bruce Chabner, MD, director of the NCI Divisionof Cancer Treatment, said that over the past decade, NCI's drugdiscovery and development programs have produced seven new drugscurrently being used to treat cancer and AIDS. The program costabout $1.4 billion: $200 million for every New Drug Applicationfiled.

Dr. Chabner made the report to the National Cancer Advisory Board'sAd Hoc Working Group on NCI Intramural Programs. He added thatduring the decade, increases in AIDS research funding has hada significant effect on the intramural research program. "Intramuralscientists have shifted the focus of their research to followthe money," he said.

Recent Videos
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
Dordaviprone was recommended at a dose of 625 mg orally once weekly for adults, and the recommended dosage is based on body weight for pediatric patients.
Extended follow-up for individuals with H3 K27M-mutated diffuse midline glioma may help explain the duration of response across patient subgroups.
Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, described the excitement of seeing novel molecules like antibody drug conjugates become more prominent.
Ronald Bleday, MD, credits a chronic pain clinic for consulting patients who may be at a greater risk for prolonged opioid use following surgery.
Related Content